Rapid Micro Biosystems
RPID
28 hedge funds and large institutions have $40.4M invested in Rapid Micro Biosystems in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
276% more capital invested
Capital invested by funds: $10.8M → $40.4M (+$29.7M)
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
47% more funds holding
Funds holding: 19 → 28 (+9)
7.86% more ownership
Funds ownership: 31.67% → 39.53% (+7.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.35M |
| 2 |
AWGLSCP
ABG-WTT Global Life Science Capital Partners
Central, Hong Kong,
Hong Kong
|
+$1.85M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.68M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$404K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$386K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$165K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$64.8K |
| 3 |
Millennium Management
New York
|
-$55.2K |
| 4 |
Mariner
Overland Park,
Kansas
|
-$25K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $288 | -$109 | -48 | -31% |
|
27
UBS Group
Zurich,
Switzerland
| $55 | +$48 | +21 | New |
|
|
SS
28
SBI Securities
Tokyo,
Japan
| $40 | +$34 | +15 | New |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$64.8K | -72,024 | Closed |
|
|
30
Millennium Management
New York
| – | -$55.2K | -61,375 | Closed |
|
|
XT
31
XTX Topco
George Town,
Cayman Islands
| – | -$16.4K | -18,201 | Closed |
|
|
VF
32
Virtu Financial
New York
| – | -$11K | -12,594 | Closed |
|
RPID Hedge Fund Activity: Q1 2025 in Review
28 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q1 2025, worth a combined $40.4M — up 276% from $10.8M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RPID positions and 4 closed out — a net gain of 9 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $2.35M. The largest seller was Renaissance Technologies, cutting an estimated $165K.
- 28 institutional investors held Rapid Micro Biosystems (RPID) as of Q1 2025, up from 19 in Q4 2024.
- Funds reported $40.4M of Rapid Micro Biosystems stock for Q1 2025, up 276% quarter-over-quarter.
- 13 funds opened new Rapid Micro Biosystems positions in Q1 2025 and 4 closed out, a net change of +9 holders.
- The largest Rapid Micro Biosystems buyer in Q1 2025 was Schonfeld Strategic Advisors, an estimated $2.35M added.
- The largest Rapid Micro Biosystems seller in Q1 2025 was Renaissance Technologies, an estimated $165K sold.
Based on aggregated 13F filings for Q1 2025.